ACTRIMS Forum 2021: Early Changes in Plasma Glial Fibrillary Acidic Protein Level May Predict Disability Progression During Siponimod Therapy for Multiple Sclerosis
In contrast, changes in plasma neurofilament light chain were not as predictive
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.